Información del producto
BMS 566419 is a calcineurin inhibitor that has been approved for the treatment of multiple sclerosis. It is also used to prevent organ rejection in transplant patients who have received a new heart, kidney, or liver. BMS 566419 has been shown to inhibit the production of hydroxyproline and collagen by inhibiting the activity of inosine monophosphate dehydrogenase. This drug is taken orally and shows dose-dependent pharmacokinetic properties. The pharmacokinetic profile of this drug can be influenced by other drugs that are also metabolized by CYP3A4 enzymes (e.g., cyclosporin A).
Propiedades químicas
Consulta técnica sobre: 3D-RXA16124 BMS 566419
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.